Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-029858
Filing Date
2026-03-18
Accepted
2026-03-18 07:12:44
Documents
110
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K plx-20251231x10k.htm   iXBRL 10-K 2700446
2 EX-4.4 plx-20251231xex4d4.htm EX-4.4 18195
3 EX-23.1 plx-20251231xex23d1.htm EX-23.1 4645
4 EX-31.1 plx-20251231xex31d1.htm EX-31.1 11377
5 EX-31.2 plx-20251231xex31d2.htm EX-31.2 11003
6 EX-32.1 plx-20251231xex32d1.htm EX-32.1 5598
7 EX-32.2 plx-20251231xex32d2.htm EX-32.2 5511
8 GRAPHIC plx-20251231x10k001.jpg GRAPHIC 44478
9 GRAPHIC plx-20251231x10k002.jpg GRAPHIC 45532
10 GRAPHIC plx-20251231x10k003.jpg GRAPHIC 58451
11 GRAPHIC plx-20251231x10k004.jpg GRAPHIC 52258
12 GRAPHIC plx-20251231x10k005.jpg GRAPHIC 38391
13 GRAPHIC plx-20251231x10k006.jpg GRAPHIC 56626
14 GRAPHIC plx-20251231x10k007.jpg GRAPHIC 40218
15 GRAPHIC plx-20251231x10k009.jpg GRAPHIC 2187
16 GRAPHIC plx-20251231xex23d1001.jpg GRAPHIC 3107
  Complete submission text file 0001104659-26-029858.txt   11632079

Data Files

Seq Description Document Type Size
17 EX-101.SCH plx-20251231.xsd EX-101.SCH 71453
18 EX-101.CAL plx-20251231_cal.xml EX-101.CAL 76404
19 EX-101.DEF plx-20251231_def.xml EX-101.DEF 278621
20 EX-101.LAB plx-20251231_lab.xml EX-101.LAB 523424
21 EX-101.PRE plx-20251231_pre.xml EX-101.PRE 478010
116 EXTRACTED XBRL INSTANCE DOCUMENT plx-20251231x10k_htm.xml XML 1873316
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 26765222
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)